Mayo Clinic Research

Trending/Mayo Clinic Research

a Mayo Clinic medical person, a while woman, in full PPE preparing a patient for monoclonal antibody transfusion

Monoclonal antibody treatment combo reduces hospitalization among high-risk patients with COVID-19

ROCHESTER, Minn. ― In an observational study, Mayo Clinic researchers report that the combination of casirivimab and imdevimab ― two monoclonal antibody treatments under Food…

Sign up